Skip to main content

Table 5 Prescription of ACT for all patients in post- and pre-RDT implementation areas with ACT in stock at health facility

From: Increased use of malaria rapid diagnostic tests improves targeting of anti-malarial treatment in rural Tanzania: implications for nationwide rollout of malaria rapid diagnostic tests

Characteristic Ifakara HDSS (pre-mRDT implementation) Rufiji HDSS (post-mRDT implementation) P-value (site)
  n/N %(95% CI) n/N %(95% CI)  
All patients treated with ACT (overall) 241/587 41.1 (33.4-49.2) 217/666 32.6 (26.5-39.4) 0.10
 High transmission season (March 2010) 155/332 46.7 (38.9-54.6) 119/349 34.1 (27.9-40.9) 0.02
 Low transmission season (October 2010) 86/255 33.7 (22.6-47.0) 98/317 30.9 (20.7-43.4) 0.74
Correct treatment: Patients with uncomplicated malaria treated with ACT (overall) 26/37 70.3 (54.7-82.2) 76/94 80.9 (68.2-89.3) 0.22
 High transmission season (March 2010) 14/24 58.3 (39.4-75.1) 61/71 85.9 (72.0-93.6) 0.01
 Low transmission season (October 2010) 12/13 92.3 (54.2-99.2) 15/23 65.2 (36.2-86.1) 0.11
Over treatment: Patients without uncomplicated malaria treated with ACT (overall) 215/550 39.1 (31.0-47.8) 141/572 24.7 (18.4-32.2) 0.01
 High transmission season (March 2010) 141/308 45.8 (37.2-54.6) 58/278 20.9 (14.7-28.8) <0.01
 Low transmission season (October 2010) 74/242 30.6 (19.6-44.3) 83/294 28.2 (18.2-41.1) 0.78